Recent MD Labs Ruling Has Implications for Test Requisitions and Commissions
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
A federal appeals court upheld the idea that clinical laboratories can rely on physician orders to justify medical necessity
Recent False Claims Act settlements underscore the government’s emphasis on individual accountability in healthcare fraud matters
Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
COVID-19-related schemes dominated recent enforcement efforts, which include a national healthcare fraud enforcement action
Genetic testing related fraud was a theme in recent enforcement actions involving medical laboratories and lab testing
Examining DOJ and OIG investigations of labs and their owners: Recent cases show continued focus on the usual enforcement targets.
Recent enforcement actions and court cases include kickback schemes a-plenty and a reminder to focus on HIPAA compliance
Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.
Recent cases show labs should be wary of issues such as improper relationships, medical necessity, kickbacks, and potential telehealth fraud.